Oct 20, 2016 11:30 am UTC| Business
HOPKINTON, Mass., Oct. 20, 2016 -- Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, cancer, and...
Oct 20, 2016 11:30 am UTC| Business
-- Study expected to provide proof-of-concept data in NASH for the first liver-directed, thyroid hormone receptor (THR) ß-selective agonist – -- Primary endpoint is the reduction of liver fat, assessed by MRI-PDFF, at 12...
Advaxis Initiates Combination Portion of Phase 1/2 Study with Merck
Oct 20, 2016 11:30 am UTC| Business
KEYNOTE-046 study to evaluate KEYTRUDA® in combination with ADXS-PSA Advaxis begins screening patients for Phase 3 AIM2CERV study in cervical cancer PRINCETON, N.J., Oct. 20, 2016 -- Advaxis, Inc. (NASDAQ:ADXS),...
Oct 20, 2016 11:30 am UTC| Business
SAN DIEGO, Oct. 20, 2016 -- Mad Catz Interactive, Inc. (“Mad Catz”) (NYSE MKT:MCZ) announced today that it will release its fiscal 2017 second quarter financial results for the period ended September 30, 2016, after the...
Pacira Pharmaceuticals Continues to Build Out Robust Commercial Leadership Team
Oct 20, 2016 11:30 am UTC| Business
PARSIPPANY, N.J., Oct. 20, 2016 -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced the appointment of two key individuals who will assume leadership roles within the company’s commercial organization. Thomas...
Repligen to Report Third Quarter 2016 Financial Results
Oct 20, 2016 11:30 am UTC| Business
WALTHAM, Mass., Oct. 20, 2016 -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report third quarter 2016 financial results on Thursday, November 3, 2016. The Company will issue a press release...
Oct 20, 2016 11:12 am UTC| Business
Dublin, Oct. 20, 2016 -- Research and Markets has announced the addition of the "Global Lethal and Non-lethal Directed Energy Weapons Market Analysis and Forecast (2015-2021)" report to their offering....